Satoshi Kuwabara

28.9k total citations · 3 hit papers
717 papers, 17.3k citations indexed

About

Satoshi Kuwabara is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Satoshi Kuwabara has authored 717 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 510 papers in Neurology, 230 papers in Cellular and Molecular Neuroscience and 104 papers in Pathology and Forensic Medicine. Recurrent topics in Satoshi Kuwabara's work include Peripheral Neuropathies and Disorders (280 papers), Hereditary Neurological Disorders (147 papers) and Parkinson's Disease Mechanisms and Treatments (98 papers). Satoshi Kuwabara is often cited by papers focused on Peripheral Neuropathies and Disorders (280 papers), Hereditary Neurological Disorders (147 papers) and Parkinson's Disease Mechanisms and Treatments (98 papers). Satoshi Kuwabara collaborates with scholars based in Japan, Australia and United States. Satoshi Kuwabara's co-authors include Masahiro Mori, Takamichi Hattori, Nobuhiro Yuki, Sonoko Misawa, Akiyuki Uzawa, Kazuaki Kanai, Kazue Ogawara, Michiaki Koga, Antonino Uncini and Kazumoto Shibuya and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Satoshi Kuwabara

676 papers receiving 16.9k citations

Hit Papers

Guillain-Barré syndrome 2021 2026 2022 2024 2021 2021 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Kuwabara Japan 68 12.5k 6.8k 2.3k 2.1k 1.9k 717 17.3k
David R. Cornblath United States 67 13.2k 1.1× 8.8k 1.3× 839 0.4× 1.7k 0.8× 2.8k 1.5× 148 18.1k
Richard AC Hughes United Kingdom 66 13.9k 1.1× 9.9k 1.5× 1.5k 0.6× 1.5k 0.7× 3.7k 2.0× 272 19.7k
Klaus V. Toyka Germany 66 5.2k 0.4× 4.4k 0.6× 1.4k 0.6× 2.9k 1.4× 2.2k 1.1× 202 12.7k
Marinos C. Dalakas United States 88 10.6k 0.8× 5.5k 0.8× 2.5k 1.1× 7.0k 3.3× 1.7k 0.9× 415 28.2k
P. James B. Dyck United States 81 11.4k 0.9× 7.0k 1.0× 1.2k 0.5× 4.1k 1.9× 7.4k 3.9× 438 23.4k
John W. Griffin United States 72 7.8k 0.6× 8.4k 1.2× 882 0.4× 4.2k 2.0× 3.7k 1.9× 209 18.6k
Masashi Aoki Japan 59 6.6k 0.5× 2.3k 0.3× 2.8k 1.2× 4.8k 2.3× 1.6k 0.8× 564 14.3k
Axel Petzold United Kingdom 58 5.7k 0.5× 1.6k 0.2× 4.4k 1.9× 3.1k 1.5× 1.5k 0.8× 287 13.4k
Jun‐ichi Kira Japan 57 4.9k 0.4× 2.2k 0.3× 4.5k 1.9× 3.1k 1.5× 1.4k 0.7× 568 13.8k
Fredrik Piehl Sweden 64 4.1k 0.3× 2.5k 0.4× 5.7k 2.4× 3.7k 1.8× 1.5k 0.8× 324 15.1k

Countries citing papers authored by Satoshi Kuwabara

Since Specialization
Citations

This map shows the geographic impact of Satoshi Kuwabara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Kuwabara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Kuwabara more than expected).

Fields of papers citing papers by Satoshi Kuwabara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Kuwabara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Kuwabara. The network helps show where Satoshi Kuwabara may publish in the future.

Co-authorship network of co-authors of Satoshi Kuwabara

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Kuwabara. A scholar is included among the top collaborators of Satoshi Kuwabara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Kuwabara. Satoshi Kuwabara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misawa, Sonoko, Tadamichi Denda, Takuji Suzuki, et al.. (2025). One-year incidence of chemotherapy-induced peripheral neuropathy in oxaliplatin- or taxane-based chemotherapy: a multicenter, prospective registry study (MiroCIP study). Expert Opinion on Pharmacotherapy. 26(3). 335–344. 3 indexed citations
3.
Uzawa, Akiyuki, Shigeaki Suzuki, Satoshi Kuwabara, et al.. (2023). Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Neurotherapeutics. 20(2). 518–523. 5 indexed citations
4.
Matsui, Naoko, Keiko Tanaka, Yohei Yamamoto, et al.. (2023). Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey. Neurology Neuroimmunology & Neuroinflammation. 10(6). 6 indexed citations
5.
Suzuki, Yoichi, Kazumoto Shibuya, Sonoko Misawa, et al.. (2022). Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study. BMC Neurology. 22(1). 85–85. 7 indexed citations
6.
Hiraga, Akiyuki & Satoshi Kuwabara. (2022). Ischemic Stroke Due to Metastatic Cervical Bone Tumor: The Importance of ‘Peripheral Vision’. The American Journal of Medicine. 135(7). e221–e222.
7.
Takemura, Naoki, Masahiro Mori, Yoichi Suzuki, et al.. (2021). Cryptococcal Meningitis in a Fingolimod-Treated Patient. Neurology Clinical Practice. 11(4). e549–e550. 5 indexed citations
8.
Sugimoto, Kazuo, Masahiro Mori, Jia Liu, et al.. (2021). Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 22(5-6). 388–394. 11 indexed citations
9.
Kroneberg, Daniel, Maria Rönnefarth, Sina C. Rosenkranz, et al.. (2021). Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study. JMIR Human Factors. 9(2). e26825–e26825. 2 indexed citations
10.
Asseyer, Susanna, Hiroki Masuda, Masahiro Mori, et al.. (2021). AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080370062–3080370062. 6 indexed citations
11.
Bergh, Peter Van den, Pieter A. van Doorn, Robert D. M. Hadden, et al.. (2021). European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Journal of the Peripheral Nervous System. 26(3). 242–268. 252 indexed citations breakdown →
12.
Sugiyama, Atsuhiko, Noriko Sato, Yukio Kimura, et al.. (2019). Exploring the frequency and clinical background of the “zebra sign” in amyotrophic lateral sclerosis and multiple system atrophy. Journal of the Neurological Sciences. 401. 90–94. 2 indexed citations
13.
Liu, Jia, Masahiro Mori, Kazuo Sugimoto, et al.. (2019). Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS. Journal of Neurology Neurosurgery & Psychiatry. 91(2). 132–139. 21 indexed citations
14.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2017). Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. Clinica Chimica Acta. 469. 144–149. 34 indexed citations
15.
Shibuya, Kazumoto, Sonoko Misawa, Hideki Kimura, et al.. (2015). A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16(5-6). 353–358. 35 indexed citations
16.
Brettschneider, Johannes, Kimihito Arai, Kelly Del Tredici, et al.. (2014). TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathologica. 128(3). 423–437. 201 indexed citations
17.
Uchiyama, Tomoyuki, Tatsuya Yamamoto, Ryuji Sakakibara, et al.. (2012). Influence of nocturnal polyuria to nocturia in Parkinson’s disease. Neurourology and Urodynamics. 1 indexed citations
18.
Yamaguchi, Chiharu, Tomoyuki Uchiyama, Tatsuya Yamamoto, et al.. (2011). Real time change of prefrontal cortex activity related to normal and abnormal bladder filling in Parkinson disease: A functional near-infared spectroscopy (fNIRS) study. Neurourology and Urodynamics.
19.
Kuwabara, Satoshi, Sonoko Misawa, Kazuaki Kanai, et al.. (2008). Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology. 71(21). 1691–1695. 68 indexed citations
20.
Tatsumoto, Muneto, Michiaki Koga, Michel Gilbert, et al.. (2006). Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Journal of Neuroimmunology. 177(1-2). 201–208. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026